NumFin

Amoy Diagnostics Co., Ltd.

Sümbol: 300685.SZ

SHZ

20.6

CNY

Turuhind täna

  • 34.8241

    P/E suhe

  • 0.0000

    PEG suhe

  • 8.13B

    MRK Cap

  • 0.01%

    DIV tootlus

Amoy Diagnostics Co., Ltd. (300685-SZ) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Amoy Diagnostics Co., Ltd. (300685.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Amoy Diagnostics Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

balance-sheet.row.cash-and-short-term-investments

00754718.7
666.4
528.5
198.3
167.8
82.3
71.9
11.5
7.7
14.7

balance-sheet.row.short-term-investments

00259.3315.9
304.9
30.1
0.1
0
0
0
0
0
0

balance-sheet.row.net-receivables

00478.8437.6
320.1
249.1
190.7
143.8
115.3
86
56.6
41
18.3

balance-sheet.row.inventory

0032.832.3
21.4
17.2
14.1
9.7
8.7
8
4.2
3.2
1.4

balance-sheet.row.other-current-assets

0019.57.4
0.9
2.7
161.9
188
-0.5
-0.6
-4.6
-3.6
-1.2

balance-sheet.row.total-current-assets

001285.11196
1008.8
797.4
564.9
509.4
205.8
165.2
67.7
48.3
33.2

balance-sheet.row.property-plant-equipment-net

00208.3209.5
170.8
143.9
144.2
129.9
128.5
105.8
88.3
40.5
12.4

balance-sheet.row.goodwill

0000
0
0
0
0
0
11.7
0
0
0

balance-sheet.row.intangible-assets

0047.219.1
16.2
15.5
15.1
15
15.4
15.7
15.6
15.9
16.2

balance-sheet.row.goodwill-and-intangible-assets

0047.219.1
16.2
15.5
15.1
15
15.4
27.3
15.6
15.9
16.2

balance-sheet.row.long-term-investments

00-200.7-248.2
-233.9
46.4
83.2
34.7
0
0
0
0
0

balance-sheet.row.tax-assets

006.520.5
18.5
7.8
2.2
1.9
2
1.7
1.5
1.7
2.2

balance-sheet.row.other-non-current-assets

00304.5323.1
312.5
35.7
9.1
38.7
1.5
2.4
3.4
4
2.9

balance-sheet.row.total-non-current-assets

00365.8323.9
284.1
249.4
253.8
185.5
147.5
137.2
108.7
62
33.7

balance-sheet.row.other-assets

01946.500
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01946.51650.91519.9
1292.9
1046.8
818.7
694.8
353.3
302.5
176.4
110.4
66.9

balance-sheet.row.account-payables

0021.324
14
16.5
13
9.6
7.6
9
12.4
2.9
0.2

balance-sheet.row.short-term-debt

005.33.1
69
5
11.7
2
10
10.7
5.7
7.6
0.2

balance-sheet.row.tax-payables

008.817.1
12.4
14.2
3.4
4.1
5.3
5
1.3
4.6
3.6

balance-sheet.row.long-term-debt-total

0048.33
2.5
0
0
0
0
0
18.1
11
0.2

Deferred Revenue Non Current

0010.311.2
14.6
4.1
5.4
6.5
8.6
8.8
8.6
8.6
11.8

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

000.60.1
57.2
4.4
3
27.5
19.1
26
44.1
40.9
37.2

balance-sheet.row.total-non-current-liabilities

0059.215
14.7
4.1
5.4
6.5
8.6
8.8
26.7
19.6
12

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

001.73
2.5
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

00151.2150.3
164.4
144.7
62
45.6
45.4
54.5
88.9
71.1
49.6

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0398.6398.2221.7
221.8
147.2
144
80
60
60
21.5
19.7
19.7

balance-sheet.row.retained-earnings

00827.7637.2
475.4
347.3
250.8
155.5
70.4
9.3
24.9
17.6
-2.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

003.591.6
51.8
6
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

01302.5270.4414.1
379.5
401.6
361.9
413.7
177.5
171.5
41.1
2
0

balance-sheet.row.total-stockholders-equity

01701.11499.71364.6
1128.5
902.1
756.7
649.2
307.9
240.9
87.5
39.3
17.3

balance-sheet.row.total-liabilities-and-stockholders-equity

001650.91519.9
1292.9
1046.8
818.7
694.8
353.3
302.5
176.4
110.4
66.9

balance-sheet.row.minority-interest

0005.1
0
0
0
0
0
7
0
0
0

balance-sheet.row.total-equity

01701.11499.71369.6
1128.5
902.1
756.7
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-

Total Investments

0058.667.6
71
76.5
83.3
32.5
0
0
0
0
0

balance-sheet.row.total-debt

0053.66.1
71.5
5
11.7
2
10
10.7
23.8
18.6
0.2

balance-sheet.row.net-debt

00-441-396.8
-290.1
-493.4
-186.5
-165.8
-72.3
-61.2
12.2
10.8
-14.5

Rahavoogude aruanne

Amoy Diagnostics Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

cash-flows.row.net-income

0256.3264.3239
180.3
135.5
126.7
94.1
65.5
18.5
19.1
22
8

cash-flows.row.depreciation-and-amortization

0052.338.9
27.3
24.2
19.7
16.4
15.1
11.9
5.7
4.4
3.4

cash-flows.row.deferred-income-tax

0013.7-1.1
-3.7
-5.6
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

00-13.71.1
3.7
5.6
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

00-58.9-125.1
-10.6
-17
-49.4
-25.1
-38
-25.3
-14.1
-19.9
-12.2

cash-flows.row.account-receivables

0025.9-132.3
-80.7
-62.3
0
0
0
0
0
0
0

cash-flows.row.inventory

00-0.6-10.8
-4.3
-3.1
-4.4
-1
-1.9
-2.8
-1
-1.8
-0.2

cash-flows.row.account-payables

00-9819.2
78
54.1
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0013.7-1.1
-3.7
-5.6
-45
-24.1
-36.1
-22.5
-13.1
-18.1
-12.1

cash-flows.row.other-non-cash-items

0-256.3-108.615.4
23.7
8.8
-3.6
6.6
-10.4
13.9
4.9
1.9
0.7

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

00-78.3-74.5
-57.9
-23.3
-39
-21.7
-45.6
-29.8
-46.2
-33.9
-24.6

cash-flows.row.acquisitions-net

0051.98.9
58
23.4
39.2
21.7
19.5
-8.9
46.5
0
24.8

cash-flows.row.purchases-of-investments

00-363.6-772.1
-1308
-30
-734.3
-370.4
-36.3
-37
-30
0
-10

cash-flows.row.sales-maturities-of-investments

00350.2600.7
1040
161.2
716.8
151.4
36.3
37.4
30.6
0
10.1

cash-flows.row.other-investing-activites

00-0.5-5.6
-57.9
-23.3
-39
0
1.6
0.5
0.3
1.9
0.2

cash-flows.row.net-cash-used-for-investing-activites

00-40.2-242.7
-325.8
108
-56.3
-240.6
-24.5
-37.7
-45.3
-32
-24.3

cash-flows.row.debt-repayment

00-1.10
-49.8
-11.7
-30.9
-10
-10.7
-33.3
-17.6
-5.2
-5

cash-flows.row.common-stock-issued

00100.70
2.8
72
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-100.7-4.4
-2.8
-0.3
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

00-51.5-55.4
-37.8
-26.5
-19.8
-0.4
-0.6
-1.5
-2
-0.4
-0.1

cash-flows.row.other-financing-activites

00-6813.5
70
5
40.6
249.2
10
110.1
53
22.2
15

cash-flows.row.net-cash-used-provided-by-financing-activities

00-120.6-46.3
-17.6
38.4
-10.1
238.8
-1.3
75.3
33.4
16.6
9.8

cash-flows.row.effect-of-forex-changes-on-cash

0024.6-10
-14.1
2.2
3.3
-4.5
4
3.6
0
-0.1
0

cash-flows.row.net-change-in-cash

0012.9-130.8
-136.8
300.2
30.4
85.6
10.4
60.3
3.8
-6.9
-14.6

cash-flows.row.cash-at-end-of-period

0244243.6230.7
361.6
498.4
198.2
167.8
82.3
71.9
11.5
7.7
14.7

cash-flows.row.cash-at-beginning-of-period

0244230.7361.6
498.4
198.2
167.8
82.3
71.9
11.5
7.7
14.7
29.3

cash-flows.row.operating-cash-flow

00149168.2
220.7
151.5
93.4
91.9
32.2
19.1
15.7
8.6
-0.2

cash-flows.row.capital-expenditure

00-78.3-74.5
-57.9
-23.3
-39
-21.7
-45.6
-29.8
-46.2
-33.9
-24.6

cash-flows.row.free-cash-flow

0070.893.6
162.8
128.2
54.5
70.2
-13.4
-10.7
-30.5
-25.3
-24.8

Kasumiaruande rida

Amoy Diagnostics Co., Ltd. tulud muutusid võrreldes eelmise perioodiga NaN%. 300685.SZ brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012

income-statement-row.row.total-revenue

01043.6842.2917
728.4
578.4
439
330.4
253
176.9
106.8
74.4
38.1

income-statement-row.row.cost-of-revenue

00147.8143.3
94.9
55.7
39.4
25.2
23.2
12.1
6.2
5
3.4

income-statement-row.row.gross-profit

01043.6694.4773.8
633.4
522.6
399.7
305.1
229.8
164.8
100.6
69.3
34.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-748.4-1.6-1.3
-1.4
-1.1
-1.5
0.6
13.2
5.5
6
9.8
5.9

income-statement-row.row.operating-expenses

0748.4524.3508.9
415
365.7
263.2
194.5
179.9
146.7
82.1
51.6
30.9

income-statement-row.row.cost-and-expenses

0748.4672.1652.2
510
421.4
302.6
219.8
203.2
158.8
88.3
56.6
34.3

income-statement-row.row.interest-income

006.13.1
6.8
13.2
2.6
1.3
0.6
0.4
0.1
0
0

income-statement-row.row.interest-expense

0010.4
0.9
0.1
0.6
0.3
0.6
1.5
0.6
0.3
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-6.4-1.6-1.3
-1.4
-1.1
-1.5
0.6
13.1
5.3
6
9.7
5.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-748.4-1.6-1.3
-1.4
-1.1
-1.5
0.6
13.2
5.5
6
9.8
5.9

income-statement-row.row.total-operating-expenses

0-6.4-1.6-1.3
-1.4
-1.1
-1.5
0.6
13.1
5.3
6
9.7
5.9

income-statement-row.row.interest-expense

0010.4
0.9
0.1
0.6
0.3
0.6
1.5
0.6
0.3
0

income-statement-row.row.depreciation-and-amortization

0-32.552.338.9
27.3
24.2
19.7
16.4
15.1
11.9
5.7
4.4
3.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0295.1287.7253.2
202.1
162.5
143.9
106.4
59.9
19.3
16.9
16.6
3.7

income-statement-row.row.income-before-tax

0288.7286.1252
200.7
161.3
142.4
106.9
73.1
24.6
22.9
26.4
9.6

income-statement-row.row.income-tax-expense

032.521.813
20.4
25.9
15.6
12.9
7.6
6.1
3.8
4.3
1.6

income-statement-row.row.net-income

0256.3263.7239.6
180.3
135.5
126.7
94.1
67
21.1
19.1
22
8
Sarnased aktsiad
Sind võib huvitada ka:
8225.HK
China Health Group Inc..
0.119 HKD
HKSE
RVTY
Revvity, Inc..
104.34 USD
NYSE
LAB
Standard BioTools Inc..
2.41 USD
NASDAQ
IDXX
IDEXX Laboratories, Inc..
500.82 USD
NASDAQ
8037.HK
China Biotech Services Holdings Limited.
0.305 HKD
HKSE
SHL.AX
Sonic Healthcare Limited.
26.655 AUD
ASX
DGX
Quest Diagnostics Incorporated.
138.16 USD
NYSE
QIA.DE
Qiagen N.V..
40.345 EUR
XETRA
603259.SS
WuXi AppTec Co., Ltd..
44.6 CNY
SHH
GTG.AX
Genetic Technologies Limited.
0.13 AUD
ASX

Korduma kippuv küsimus

Mis on Amoy Diagnostics Co., Ltd. (300685.SZ) koguvara?

Amoy Diagnostics Co., Ltd. (300685.SZ) koguvara on 1946538300.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.889.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 0.444.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.246.

Mis on ettevõtte kogutulu?

Kogutulu on 0.283.

Mis on Amoy Diagnostics Co., Ltd. (300685.SZ) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 256255700.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 0.000.

Mis on tegevuskulude arv?

Tegevuskulud on 748437800.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.